USPTO serial 87416777
Serial No. 87416777
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 23, 2018
- Examiner
- VERHOSEK, WILLIAM T
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with Serial No. 87416777?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Teewinot Life Sciences Corporation
Tampa, FL
Other trademarks owned by Teewinot Life Sciences Corporation
Teewinot Life Sciences Corporation
Tampa, FL
Other trademarks owned by Teewinot Life Sciences Corporation
Teewinot Life Sciences Corporation
Tampa, FL
Other trademarks owned by Teewinot Life Sciences Corporation
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
David D'Zurilla
DAVID D'ZURILLA SCHWEGMAN LUNDBERG & WOESSNER, P.A.P.O. BOX 2938MINNEAPOLIS, MN 55402UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical and biopharmaceutical drugs for the treatment of pain, inflammation, cancer, seizures, and epilepsy | SECTION 8 - CANCELLED | Nov 1, 2017 |
| 040 | Custom manufacture of pharmaceuticals and biopharmaceutical drugs; Custom manufacturing of new biological products for others; Custom manufacture of chemical products for others; Custom manufacture of nutraceuticals for others; Custom manufacture of cosmeceuticals for others; Custom manufacture of medical veterinary products for others | SECTION 8 - CANCELLED | Jul 1, 2016 |
| 042 | Research and development of pharmaceuticals and biopharmaceutical drugs; Medical research and development in the field of synthetic biology, molecular biology, genetic engineering, and organic chemistry; Research and development of new biological products for others; Research and development of new chemical products for others; Nutraceutical research and development for others; Cosmeceutical research and development for others; Veterinary medical research and development for others; Research and development in the field of bioinformatics and proteomics | SECTION 8 - CANCELLED | Jul 1, 2016 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Teewinot Life Sciences Corporation
- Other trademarks owned by Teewinot Life Sciences Corporation
- Other trademarks owned by Teewinot Life Sciences Corporation
- Other trademarks in Class 005
- Other trademarks in Class 040
- Other trademarks in Class 042
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 2, 2024 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Jan 23, 2023 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jan 23, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 20, 2017 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Dec 19, 2017 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Dec 19, 2017 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Dec 15, 2017 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Dec 1, 2017 | IUAF | USE AMENDMENT FILED | — |
| Dec 1, 2017 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Oct 10, 2017 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Aug 15, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 15, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 26, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 13, 2017 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 13, 2017 | ALIE | ASSIGNED TO LIE | — |
| Jun 8, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 7, 2017 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 7, 2017 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 7, 2017 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 7, 2017 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 6, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 26, 2017 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Apr 25, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 22, 2017 | NWAP | NEW APPLICATION ENTERED | — |